When most people think about psychedelic therapy, they often imagine resistance, fear, or skepticism from patients who might be uncomfortable with the idea of altered consciousness as part of their mental health treatment. However, recent research reveals a surprising truth: the majority of psychiatric patients...
In February 2024, a scientific paper made headlines with a bold claim: among all the psychedelics being studied for mental health treatment, only DMT (dimethyltryptamine) showed a "statistically significant association with an increase in peripheral BDNF levels" in humans [1]. BDNF, or brain-derived neurotrophic factor,...
When Jennifer first considered psilocybin therapy for her treatment-resistant depression, her biggest concern wasn't about side effects or safety protocols. As a deeply religious person, she worried about how a psychedelic experience might affect her faith. Would it challenge her beliefs? Would it bring her...
The COVID-19 pandemic created an unprecedented global mental health crisis that challenged traditional approaches to psychological care and revealed significant gaps in our mental health infrastructure. As lockdowns isolated people from their support systems, economic uncertainty threatened livelihoods, and the constant threat of illness created...